Calls
1
u/Heartyprofitcalm
Reddit r/IndianStockMarket
Win Rate
100.0%
return
+2.6%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 24
$1323.00
+2.6%
Cipla is the exclusive India partner for Eli Lilly's blockbuster GLP-1 drug tirzepatide, which is scaling faster than any drug in history and addresses large under-penetrated obesity and diabetes markets. The author believes Cipla is plugged into this megatrend without R&D risk and will likely manufacture tirzepatide in India, with patent protection until 2036. This partnership is seen as a multi-year growth driver that the market is underpricing, potentially making Cipla the biggest pharma stock in India over the next 10 years.
Other
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/Heartyprofitcalm has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: CIPLA.NS.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
